Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by bionicjoeon Jun 25, 2019 11:05am

60 Views

Post# 29860378

RE:conclusions of our pre-clinical research

floatinketucky wrote: The signifigance of the pr: GMB preclinical research concluded.

Submissions for PH 1 clinical forthcoming...

The conclusions of our pre-clinical research are compelling and we are looking forward to future submissions to Health Canada and the FDA regulatory applications to evaluate Rutherrin® PDT in a Phase Ib clinical study for patients inflicted with GBM."

https://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=6187259643193135&topic=TLTFF&symbology=null&cp=null&webmasterId=90338